Search for: "ELI LILLY & CO." Results 621 - 640 of 1,009
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
28 Sep 2011, 1:56 am by Marie Louise
  Highlights this week included: US: CAFC: Patent exhaustion does not apply to genetically engineered seed: Monsanto Co. v. [read post]
6 Jan 2010, 2:05 pm by Tom Lamb
  From a December 23, 2009 Bloomberg article, "Amylin Falls as Analyst Says FDA Wants Byetta Study", by reporter Rob Waters: San Diego-based Amylin and Indianapolis-based Eli Lilly & Co., which co-market the drug, announced Oct. 30 that the Food and Drug Administration had cleared the drug for use as standalone therapy for Type 2 diabetics and that prescribing information would warn about the risk of pancreatitis, an inflamed pancreas, in… [read post]
31 Mar 2016, 6:40 am by Tom Lamb
" Dr Peters, who also writes a column for Medscape Diabetes & Endocrinology, has served as a speaker or consultant with Eli Lilly, Boehringer Ingelheim Pharmaceuticals, and AstraZeneca Pharmaceuticals, which make SGLT-2 inhibitors. [read post]
18 Jul 2014, 11:55 am
This post is only from the Reed Smith (more properly, the non-Dechert) side of the blog.One hundred what, you say? [read post]
6 Feb 2019, 4:27 am
Ever since Actavis v Eli Lilly ([2017] UKSC 48) dragged equivalence into the UK patent infringement system there has been an open question regarding the future of the so-called 'Gillette defence'. [read post]
24 Dec 2009, 12:28 am
A Philadelphia judge dismissed the two remaining claims the Pennsylvania Employees Benefit Trust Fund had brought against Eli Lilly & Co. over its marketing of Zyprexa on Dec. 10. [read post]
10 Jan 2012, 11:58 pm by Lawrence B. Ebert
Eli Lilly & Co., 598 F.3d 1336, 1351 (Fed. [read post]
27 Feb 2009, 5:00 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: [duncanbucknell.com]   Highlights this week included: Evista (Raloxifene) – US: CAFC affirms extension of 30-month stay against Teva’s generic Evista: Eli Lilly & Co v Teva Pharmas. [read post]
3 Apr 2017, 1:00 am by Matrix Legal Support Service
On Tuesday 4 April until Thursday 6 April, the Supreme Court will hear the appeal of Eli Lilly & Co v Actavis UK Ltd & Ors, and other cases. [read post]
9 Nov 2009, 6:01 am
. $7 Billion in Penalties Since May 2004, Pfizer, Eli Lilly & Co., Bristol-Myers Squibb Co. and four other drug companies have paid a total of $7 billion in fines and penalties. [read post]
14 Feb 2007, 6:52 pm
As a result of this case the Supreme People's Court recognised declaration of non-infringement as a proper cause of action.Since this case there have been non-infringement suits in China involving patents, trademarks and copyright.As a result of Eli Lilly versus Changzhou Huasheng Pharmaceutical Co. [read post]